Weiss Amir — SEC insider filings
SEC reporting owner CIK 1897057. 22 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2022-03-02 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 8 filings — 123,895 shares, $3,039,269 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
- Largest priced transaction: sale of 9,534 shares @ $43.03 ($410,238) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2026-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 22 | — | 12 legs · 123,895 sh · $3,039,269 | 49 |
Insider filings — Weiss Amir
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 7,755 @ $34.70 · Sale (S): 662 @ $43.15 · Sale (S): 7,093 @ $43.03 · Sale (S): 9,534 @ $43.03 · Option exercise (M): 7,755 (derivative) @ $0 | EDGAR |
| 2026-08-25 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 6,945 @ $37.61 · Option exercise (M): 2,500 @ $19.61 · Sale (S): 2,500 @ $37.63 · Option exercise (M): 2,500 (derivative) @ $19.16 | EDGAR |
| 2026-05-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 10,679 @ $36 | EDGAR |
| 2026-03-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 3,537 · Option exercise (M): 3,537 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 10,679 · Option exercise (M): 5,650 · Option exercise (M): 10,679 (derivative) @ $0 · Option exercise (M): 5,650 (derivative) @ $0 · Grant/award (A): 11,280 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 5,179 · Option exercise (M): 5,179 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 12,300 @ $30.20 | EDGAR |
| 2025-11-10 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 12,300 @ $24.44 | EDGAR |
| 2025-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 3,566 · Option exercise (M): 3,566 (derivative) @ $0 · Grant/award (A): 14,150 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 10,676 · Option exercise (M): 5,650 · Option exercise (M): 10,676 (derivative) @ $0 · Option exercise (M): 5,650 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 5,179 · Option exercise (M): 5,179 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 15,500 @ $16.80 · Sale (S): 12,635 @ $16.65 | EDGAR |
| 2024-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 3,564 · Option exercise (M): 3,564 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 5,179 · Option exercise (M): 10,676 · Option exercise (M): 5,179 (derivative) @ $0 · Option exercise (M): 10,676 (derivative) @ $0 · Grant/award (A): 22,600 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 3,219 · Option exercise (M): 3,219 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 31,766 @ $12.37 | EDGAR |
| 2023-08-07 | 4/A | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Holdings only — no transactions reported | EDGAR |
| 2023-08-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 1,981.41 @ $9.92 | EDGAR |
| 2023-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 2,406 · Option exercise (M): 10,676 · Option exercise (M): 3,564 · Grant/award (A): 20,717 (derivative) @ $0 · Option exercise (M): 2,406 (derivative) @ $0 · Option exercise (M): 10,676 (derivative) @ $0 · +1 more | EDGAR |
| 2023-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 3,219 · Option exercise (M): 3,219 (derivative) @ $0 | EDGAR |
| 2022-03-08 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 2,403 · Option exercise (M): 3,564 · Option exercise (M): 2,403 (derivative) @ $0 · Grant/award (A): 42,707 (derivative) @ $0 · Option exercise (M): 3,564 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 3,219 · Option exercise (M): 981 · Option exercise (M): 3,219 (derivative) @ $0 · Option exercise (M): 981 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1897057 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs